SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022927
Filing Date
2020-05-07
Accepted
2020-05-07 16:33:46
Documents
73
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q svra-10q_20200331.htm 10-Q 1910090
2 EX-10.1 svra-ex101_313.htm EX-10.1 307780
3 EX-31.1 svra-ex311_6.htm EX-31.1 14777
4 EX-31.2 svra-ex312_8.htm EX-31.2 14529
5 EX-32.1 svra-ex321_7.htm EX-32.1 10681
  Complete submission text file 0001564590-20-022927.txt   7832300

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT svra-20200331.xml EX-101.INS 1658624
7 XBRL TAXONOMY EXTENSION SCHEMA svra-20200331.xsd EX-101.SCH 72365
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE svra-20200331_cal.xml EX-101.CAL 52642
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE svra-20200331_def.xml EX-101.DEF 172530
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20200331_lab.xml EX-101.LAB 487997
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20200331_pre.xml EX-101.PRE 347120
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 20857021
SIC: 2834 Pharmaceutical Preparations